George L. King

Senior Vice President & Chief Scientific Officer at Joslin Diabetes Center at the Harvard Stem Cell Institute

George L. King

George L. King

Senior Vice President & Chief Scientific Officer at Joslin Diabetes Center at the Harvard Stem Cell Institute

Biography

George L. King is Chief Scientific Officer & Senior Vice President at Joslin Diabetes Center. He received a doctorate from Duke University School of Medicine.

Overview
RelSci Relationships

421

Number of Boards

3

Relationships
RelSci Relationships are individuals George L. King likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former President & Chief Executive Officer at Joslin Diabetes Center at the Harvard Stem Cell Institute

Relationship likelihood: Strong

Chief Medical Officer & Senior Vice President at Joslin Diabetes Center at the Harvard Stem Cell Institute

Relationship likelihood: Strong

Member, Board of Trustees at Joslin Diabetes Center at the Harvard Stem Cell Institute

Relationship likelihood: Strong

Chief Financial Officer & Executive Vice President at Randolph Bancorp, Inc.

Relationship likelihood: Strong

Founder at CeQur SA

Relationship likelihood: Strong

Senior Vice President & General Counsel at Enanta Pharmaceuticals, Inc.

Relationship likelihood: Strong

Vice President of Engineering, Technology & Mission Assurance at Raytheon Company

Relationship likelihood: Strong

Professor of the Division of Endocrinology, Department of Medicine at University of Pennsylvania - Perelman School of Medicine

Relationship likelihood: Strong

Co-Founder at Audax Group LP

Relationship likelihood: Strong

President & Chief Executive Officer at Tekla Capital Management LLC

Relationship likelihood: Strong

Paths to George L. King
Potential Connections via
Relationship Science
You
George L. King
Senior Vice President & Chief Scientific Officer at Joslin Diabetes Center at the Harvard Stem Cell Institute
Education

Duke Medicine conceptually integrates the Duke University Health System, the Duke University School of Medicine, and the Duke University School of Nursing. It is the combination of research, clinical care, and education that takes place through the efforts of our faculty, staff, students, and trainees at many different sites throughout our region and worldwide. In 2006, Duke Medicine adopted new mission and vision statements that describe the overarching goals and shared aspirations of all of its components -- including the Duke University Health System, the Duke University School of Medicine, and the Duke University School of Nursing. We also finalized strategic plans to guide our efforts over the next five to 10 years.

Career History
Senior Vice President & Chief Scientific Officer
Current

Joslin Diabetes Center develops pharmaceuticals for diabetes. The firm develops and disseminates patient therapies and scientific discoveries throughout the world. The company was founded in 1898 and is headquartered in Boston, MA.

Boards & Committees
Member, Scientific Advisory Board
Current

Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. The firm also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. The company was founded in 1992 and is headquartered in London, Canada.

Ex Officio Member, Board of Trustees
Current

Joslin Diabetes Center develops pharmaceuticals for diabetes. The firm develops and disseminates patient therapies and scientific discoveries throughout the world. The company was founded in 1898 and is headquartered in Boston, MA.

Member, Board of Directors
Prior

American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$5,000 - $10K
2012

Joslin Diabetes Center develops pharmaceuticals for diabetes. The firm develops and disseminates patient therapies and scientific discoveries throughout the world. The company was founded in 1898 and is headquartered in Boston, MA.

$10K - $25K
2011

Joslin Diabetes Center develops pharmaceuticals for diabetes. The firm develops and disseminates patient therapies and scientific discoveries throughout the world. The company was founded in 1898 and is headquartered in Boston, MA.

$5,000 - $10K
2010

Joslin Diabetes Center develops pharmaceuticals for diabetes. The firm develops and disseminates patient therapies and scientific discoveries throughout the world. The company was founded in 1898 and is headquartered in Boston, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by George L. King. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of George L. King's profile does not indicate a business or promotional relationship of any kind between RelSci and George L. King.